Oncoinvent to present three abstracts at EANM and ESMO 2026
Oslo, Norway – 30 September 2026 – Oncoinvent, a clinical-stage radiopharmaceutical company developing Radspherin®, a receptor-independent alpha-emitting therapy to eradicate cancer cells in the abdominal cavity after surgery with a single, targeted dose, today announces that three abstracts from its Radspherin® program have been accepted for presentation at the European Association of Nuclear Medicine (EANM) Annual Congress 2026 in Vienna, Austria (17-21 October) and the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (23-27 October).
The accepted abstracts highlight key areas of the Radspherin® program, including Radium-224 production technology, radiation dosimetry and the ongoing Phase 2 clinical evaluation of Radspherin® in ovarian cancer. Two abstracts will be presented at EANM and one at ESMO.
Øystein Soug, Chief Executive Officer of Oncoinvent, said: “We are pleased to have three abstracts accepted for presentation at EANM and ESMO 2026. Together, they highlight research across the Radspherin® program, from Radium-224 production and radiation dosimetry to ongoing clinical development in ovarian cancer. We look forward to sharing our work with the scientific community at both meetings.”
EANM 2026:
| Abstract Title: | A228Th/224Ra Generator Based on Citrate Solution for Production of High-Purity 224Ra for Radiopharmaceuticals |
| Session Title: | The Science of Radiopharmaceutical Preparation |
| Date & Time: | Monday, 19 October 2026, 08:48 – 08:52 CEST |
| Location: | Hall G2 |
| Session number: | EPS-098 |
| Session Number: | 709 |
| Abstract Title: | Dosimetry of the Peritoneum from Radium-224 Calcium Carbonate Microparticles Estimated Using Monte Carlo Simulations |
| Format: | Digital e-Poster |
| Session Number: | EP-67 |
ESMO 2026:
| Abstract Title: | A Phase 2 Randomised Trial of Intraperitoneal α-emitting Radium 224 for Homologous Recombination Proficient Primary Advanced Epithelial Ovarian Cancer - Trial in Progress |
| Session Title: | Gynaecological cancers |
| Date & Time: | Saturday, 24 October 2026, 14 |
| Location: | Barcelona Auditorium - Hall 9 |
| Presentation Number: | 1446eTiP |
| Presentation Format: | e-Poster |
***